News release

Date: 17th March 2015

Advanced research instrumentation specialists Oxford Optronix to showcase solutions at The Genes & Cancer Meeting in Cambridge, UK

Oxford Optronix team to meet with specialists from across cancer research field at key UK meeting from 13-15 April 2015

Abingdon, UK, 17th March 2015Oxford Optronix, the leading provider of advanced research instrumentation for the clinical medicine and life science industries, today announces that it will be showcasing its full range of cancer research solutions at The Genes & Cancer Annual Meeting at Robinson College, Cambridge, UK, from 13 - 15 April 2015.

Oxford Optronix will be exhibiting throughout the two-day event, which is now in its 31st year and is the longest-running cancer research meeting in the UK. The Oxford Optronix team will demonstrate its full range of advanced instrumentation products, including the next-generation OxyLite™ dissolved oxygen (pO2) and temperature monitors, the GelCount™ colony counter platform for cancer biologists and its recently launched HypoxyLab™ hypoxia workstation.
The Genes & Cancer Annual Meeting has built a solid reputation for highlighting the very latest advances in cancer research. Key topics under discussion at this year’s gathering will include ‘cell growth and survival of the cancer cell’, ‘engagement of immune cells’, ‘cancer as a systemic disease’, ‘detection and imaging’ and ‘models and therapy’. In addition, and in line with a commitment to promote early career scientists, the programme will also feature 10 short talks, selected from submitted abstracts.

The Oxford Optronix team will be on hand during the show to demonstrate its products, answer any questions, and to learn first-hand about the key developments and potential breakthroughs in this vital area. Oxford Optronix’s bio-sensing solutions for tissue vitality, automated cell colony counting system, and new hypoxia workstation have all proved highly successful across a range of research disciplines, with particular application in oncology.

For more information about The Genes & Cancer Meeting, and to register, please visit: and follow the hashtag #GANDC2015 on Twitter.

--- ends ---

Note to editors:
If you would be interested in scheduling a briefing with Oxford Optronix, please contact Nicky Denovan at nicky[at]evokedset[dot]com.

Press contacts:
Nicky Denovan
EvokedSet PR
nicky [at] evokedset [dot] com
Phone: +44 (0)7747 017654

About Oxford Optronix (
Oxford Optronix is a global pioneer in the design, development and manufacture of sophisticated instrumentation for clinical medicine and life science research.
Founded and managed by academic scientists and with a focus on continuous research and development, Oxford Optronix is committed to making a positive contribution to both patient care and life science research through the design and development of innovative medical devices and scientific instruments for research professionals that set the gold-standard for quality.
Oxford Optronix’s product range includes opto-electronic bio-sensing devices for physiological and tissue vitality monitoring, intelligent imaging systems for automated cell colony counting and contamination-free hypoxia workstations for analysing cell metabolism and function.
With a track record of over 20 years’ success, Oxford Optronix’s team of highly experienced scientists, engineers and technicians design, develop and manufacture its entire product portfolio in-house, ensuring the very highest standards in quality and unparalleled customer support.


Close This Window